Mesylate solvate crystal of nicotinamide derivatives and preparation method and application of mesylate solvate crystal
A technology of mesylate and nicotinamide is applied in the field of mesylate solvate crystals of nicotinamide derivatives and the preparation thereof, and can solve the problems affecting the curative effect, stability and bioavailability of drugs, etc. The effect of significant bioavailability and good high temperature stability
Active Publication Date: 2014-10-08
SHANGHAI SUNTRONG BIOTECH
View PDF7 Cites 5 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0003] As we all know, different crystal forms of the same drug may have significant differences in their stability and bioavailability, which will affect the efficacy of the drug
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0042] Dissolve 90mg of pyridinecarboxamide derivatives in 3ml of dimethylformamide, slowly add 6ml of isopropanol at room temperature, and leave it sealed for 72 hours. The precipitated crystals are mesylate dimethylformamide solvate crystals.
Embodiment 2
[0044] Dissolve 90mg of pyridinecarboxamide derivatives in 3ml of dimethylformamide, slowly add 6ml of acetone at room temperature, and seal it for 72 hours. The precipitated crystals are mesylate dimethylformamide solvate crystals.
Embodiment 3
[0046] Dissolve 90mg of pyridinecarboxamide derivatives in 3ml of dimethylformamide, slowly add 6ml of methyl ethyl ketone at room temperature, and seal it for 72 hours. The precipitated crystals are mesylate dimethylformamide solvate crystals .
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More Abstract
The invention discloses a mesylate solvate crystal of nicotinamide derivatives and a preparation method and application of the mesylate solvate crystal. The mesylate solvate crystal of nicotinamide derivatives is a mesylate dimethylformamide solvate crystal and has the characteristic parameters that the crystal system is a triclinic system; the space group is P-1; the cell parameters are as follows: a is 8.9418(2) angstrom, b is 9.4513(2) angstrom, c is 19.5111(4) angstrom, alpha is 76.489(1), beta is 84.199(1), and gamma is 61.952(1); the cell volume V is 1414.91(5) cubic angstrom; the number Z of asymmetry units in cells is equal to 2. The mesylate solvate crystal of nicotinamide derivatives provided by the invention has high high-temperature stability, high humidity stability and illumination stability, is applied to medicines for treating advanced non-small cell lung cancer, gastric carcinoma, liver cancer or breast cancer and is obvious in bioavailability, and the provided qualitative and quantitative information has significance for further researching the curative effect of the solid drugs.
Description
technical field [0001] The invention relates to molecular targeting antineoplastic drugs, in particular to mesylate solvate crystals of nicotinamide derivatives, a preparation method and application thereof. Background technique [0002] Niacinamide derivatives (aptinib), molecular formula C 25 h 27 N 5 o 4 S, whose chemical name is N-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridinecarboxamide, is a molecularly targeted antineoplastic drug, It is a typical small molecule vascular endothelial growth factor tyrosine kinase inhibitor, which can be used to treat advanced non-small cell lung cancer, gastric cancer, liver cancer and breast cancer. Chinese invention patent CN101676267 discloses the preparation method and application of the above nicotinamide derivative methanesulfonate. [0003] As we all know, different crystal forms of the same drug may have significant differences in stability and bioavailability, which will affect the efficacy of the drug...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More Patent Type & Authority Applications(China)
IPC IPC(8): C07D213/82C07C309/04C07C303/44A61K31/455A61P35/00
CPCC07D213/82
Inventor 于迎渌陈金瑶弋东旭
Owner SHANGHAI SUNTRONG BIOTECH
